Healthcare provider profile · identity verified

Irina Licea, MD

Family Practice · MIAMI, FL · NPI 1649454091

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Eliquis	Apixaban	501	43
Atorvastatin Calcium	Atorvastatin Calcium	291	63
Levothyroxine Sodium	Levothyroxine Sodium	287	32
Amlodipine Besylate	Amlodipine Besylate	284	53
Metoprolol Tartrate	Metoprolol Tartrate	273	50
Gabapentin	Gabapentin	242	41
Trazodone Hcl	Trazodone Hcl	214	30
Pantoprazole Sodium	Pantoprazole Sodium	208	50
Furosemide	Furosemide	200	38
Metformin Hcl	Metformin Hcl	185	41
Losartan Potassium	Losartan Potassium	167	34
Sertraline Hcl	Sertraline Hcl	164	21
Lisinopril	Lisinopril	157	28
Tamsulosin Hcl	Tamsulosin Hcl	155	27
Rosuvastatin Calcium	Rosuvastatin Calcium	145	30
Clopidogrel	Clopidogrel Bisulfate	144	23
Carvedilol	Carvedilol	142	27
Memantine Hcl	Memantine Hcl	139	22
Quetiapine Fumarate	Quetiapine Fumarate	118	22
Mirtazapine	Mirtazapine	114	25
Levetiracetam	Levetiracetam	108	19
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	97	38
Escitalopram Oxalate	Escitalopram Oxalate	89	15
Hydralazine Hcl	Hydralazine Hcl	84	19
Ibuprofen	Ibuprofen	84	24
Montelukast Sodium	Montelukast Sodium	80	15
Latanoprost	Latanoprost	78	16
Baclofen	Baclofen	77	15
Potassium Chloride	Potassium Chloride	77	20
Famotidine	Famotidine	76	19
Lactulose	Lactulose	72	14
Duloxetine Hcl	Duloxetine Hcl	69	11
Nifedipine Er	Nifedipine	69	suppressed
Xarelto	Rivaroxaban	66	suppressed
Spironolactone	Spironolactone	63	12
Benztropine Mesylate	Benztropine Mesylate	62	11
Ssd	Silver Sulfadiazine	60	18
Donepezil Hcl	Donepezil Hcl	58	12
Alendronate Sodium	Alendronate Sodium	57	suppressed
Entresto	Sacubitril/Valsartan	57	12
Midodrine Hcl	Midodrine Hcl	57	14
Metoprolol Succinate	Metoprolol Succinate	56	12
Januvia	Sitagliptin Phosphate	55	suppressed
Scopolamine	Scopolamine	53	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	48	11
Finasteride	Finasteride	46	11
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	45	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	45	suppressed
Simvastatin	Simvastatin	45	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	42	14
Risperidone	Risperidone	42	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	42	suppressed
Clonidine Hcl	Clonidine Hcl	40	14
Fenofibrate	Fenofibrate Nanocrystallized	40	suppressed
Ketoconazole	Ketoconazole	40	12
Ciprofloxacin Hcl	Ciprofloxacin Hcl	39	29
Glipizide	Glipizide	39	12
Nystatin	Nystatin	39	16
Carbidopa-Levodopa	Carbidopa/Levodopa	38	suppressed
Methocarbamol	Methocarbamol	38	11
Phenobarbital	Phenobarbital	38	suppressed
Azithromycin	Azithromycin	37	29
Divalproex Sodium	Divalproex Sodium	37	13
Allopurinol	Allopurinol	36	suppressed
Labetalol Hcl	Labetalol Hcl	36	suppressed
Timolol Maleate	Timolol Maleate	36	suppressed
Meropenem	Meropenem	35	suppressed
Omeprazole	Omeprazole	35	11
Doxazosin Mesylate	Doxazosin Mesylate	34	suppressed
Amiodarone Hcl	Amiodarone Hcl	33	suppressed
Citalopram Hbr	Citalopram Hydrobromide	32	suppressed
Glimepiride	Glimepiride	32	suppressed
Humalog	Insulin Lispro	32	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	31	suppressed
Fluticasone Propionate	Fluticasone Propionate	31	11
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	30	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	29	18
Doxycycline Hyclate	Doxycycline Hyclate	28	21
Insulin Lispro	Insulin Lispro	28	12
Rexulti	Brexpiprazole	28	suppressed
Glycopyrrolate	Glycopyrrolate	27	suppressed
Mupirocin	Mupirocin	27	21
Ondansetron Hcl	Ondansetron Hcl	27	suppressed
Ondansetron Hcl	Ondansetron Hcl/Pf	27	12
Humulin R	Insulin Regular, Human	26	suppressed
Prednisone	Prednisone	26	suppressed
Sucralfate	Sucralfate	26	suppressed
Trulicity	Dulaglutide	25	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	24	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	24	suppressed
Jardiance	Empagliflozin	24	suppressed
Metformin Hcl Er	Metformin Hcl	24	suppressed
Methimazole	Methimazole	24	suppressed
Synthroid	Levothyroxine Sodium	24	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	23	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	23	suppressed
Tradjenta	Linagliptin	23	suppressed
Aptiom	Eslicarbazepine Acetate	22	suppressed
Farxiga	Dapagliflozin Propanediol	22	suppressed
Digoxin	Digoxin	21	suppressed
Ipratropium Bromide	Ipratropium Bromide	21	suppressed
Megestrol Acetate	Megestrol Acetate	21	15
Tivicay	Dolutegravir Sodium	21	suppressed
Clobetasol Propionate	Clobetasol Propionate	20	suppressed
Hydrocortisone	Hydrocortisone	20	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	20	suppressed
Sodium Chloride	0.9 % Sodium Chloride	20	suppressed
Albuterol Sulfate	Albuterol Sulfate	19	suppressed
Budesonide	Budesonide	19	suppressed
Temazepam	Temazepam	19	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	18	suppressed
Haloperidol	Haloperidol	17	suppressed
Lorazepam	Lorazepam	17	suppressed
Lubiprostone	Lubiprostone	17	suppressed
Oxcarbazepine	Oxcarbazepine	17	suppressed
Procrit	Epoetin Alfa	17	suppressed
Vancomycin Hcl	Vancomycin/Water For Inj (Peg)	17	suppressed
Atenolol	Atenolol	16	suppressed
Novolog Flexpen	Insulin Aspart	16	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Acamprosate Calcium	Acamprosate Calcium	15	suppressed
Clotrimazole	Clotrimazole	15	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	15	11
Enoxaparin Sodium	Enoxaparin Sodium	15	suppressed
Enulose	Lactulose	15	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	15	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	suppressed
Bethanechol Chloride	Bethanechol Chloride	14	suppressed
Ceftriaxone	Ceftriaxone Sodium	14	suppressed
Olanzapine	Olanzapine	14	suppressed
Pregabalin	Pregabalin	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	suppressed
Alprazolam	Alprazolam	13	suppressed
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	13	suppressed
Carbamazepine	Carbamazepine	13	suppressed
Cephalexin	Cephalexin	13	suppressed
Cilostazol	Cilostazol	13	suppressed
Clonazepam	Clonazepam	13	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	13	suppressed
Topiramate	Topiramate	13	suppressed
Valproic Acid	Valproic Acid	13	suppressed
Buspirone Hcl	Buspirone Hcl	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Lamivudine	Lamivudine	12	suppressed
Novolog	Insulin Aspart	12	suppressed
Pravastatin Sodium	Pravastatin Sodium	12	suppressed
Rivastigmine	Rivastigmine	12	suppressed
Breyna	Budesonide/Formoterol Fumarate	11	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Cefepime Hcl	Cefepime Hcl	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Levofloxacin	Levofloxacin	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Methylprednisolone	Methylprednisolone	11	suppressed
Nystop	Nystatin	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error